FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiromichi Suzuki

Research Profile

Procedures

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Rats

Physiology

Glomerular Filtration Rate

Co-author Network

Publications

TOP 3
Hiromichi Suzuki; Tsutomu Inoue; Yusuke Watanabe; Tomohiro Kikuta; Takahiko Sato; Masahiro Tsuda
Survival of patients over 75 years of age on peritoneal dialysis therapy.
Hiromichi Suzuki; Tsutomu Inoue; Yusuke Watanabe; Tomohiro Kikuta; Takahiko Sato; Masahiro Tsuda
Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
Tsutomu Inoue; Hirokazu Okada; Tsuneo Takenaka; Yusuke Watanabe; Hiromichi Suzuki
A case report suggesting the occurrence of epithelial-mesenchymal transition in obstructive nephropathy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiromichi Suzuki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Hiromichi Suzuki; Tsutomu Inoue; Yusuke Watanabe; Tomohiro Kikuta; Takahiko Sato; Masahiro Tsuda
Survival of patients over 75 years of age on peritoneal dialysis therapy.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2010;26():61-6.
2010: Hiromichi Suzuki; Tsutomu Inoue; Yusuke Watanabe; Tomohiro Kikuta; Takahiko Sato; Masahiro Tsuda
Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2010;26():53-7.
2009: Tsutomu Inoue; Hirokazu Okada; Tsuneo Takenaka; Yusuke Watanabe; Hiromichi Suzuki
A case report suggesting the occurrence of epithelial-mesenchymal transition in obstructive nephropathy.
Clinical and experimental nephrology 2009;13(4):385-8.
2008: T Takenaka; Tsutomu Inoue; Yoshihiko Kanno; Hirokazu Okada; K R Meaney; C E Hill; Hiromichi Suzuki
Expression and role of connexins in the rat renal vasculature.
Kidney international 2008;73(4):415-22.
2008: Hidetomo Nakamoto; Eiichi Nishida; Munekazu Ryuzaki; Masayoshi Sone; Hiromichi Suzuki; Mitsuo Yoshimoto; Kaoru Itagaki
Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu).
Clinical and experimental hypertension (New York, N.Y. : 1993) 2008;30(1):57-67.
2008: Tsuneo Takenaka; Tsutomu Inoue; Yoshihiko Kanno; Hirokazu Okada; Caryl E Hill; Hiromichi Suzuki
Connexins 37 and 40 transduce purinergic signals mediating renal autoregulation.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;294(1):R1-11.
2006: Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Yusuke Watanabe; Yoshihiko Kanno; Shinichi Ban; takeshi sugaya; Masatsugu Horiuchi; Hiromichi Suzuki
A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.
The American journal of pathology 2006;169(5):1577-89.
2006: Hidetomo Nakamoto; Nobuko Honda; Taku Mimura; Hiromichi Suzuki
Hypoalbuminemia is an important risk factor of hypotension during hemodialysis.
Hemodialysis international. International Symposium on Home Hemodialysis 2006;10 Suppl 2():S10-5.
2006: Hiromichi Suzuki
[Juxtaglomerular cell tumor].
Nihon rinsho. Japanese journal of clinical medicine 2006;Suppl 3():517-9.
2006: Hiromichi Suzuki
[Controversial matters in the guidelines for the therapy of patients with hypertension].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 6():531-5.
2006: Yoshihiko Kanno; Hiromichi Suzuki
[E-COST].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 6():480-5.
2006: Yoshihiko Kanno; Tsuneo Takenaka; Tsukasa Nakamura; Hiromichi Suzuki
Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(4):730-7.
2006: Naofumi Ikeda; Shigeyuki Nishimura; Shunei Kyo; Nobuyuki Komiyama; Kazuo Matsumoto; Tsutomu Inoue; Hiromichi Suzuki
Valsartan cardio-renal protection in patients undergoing coronary angiography complicated with chronic renal insufficiency (VAL-CARP) trial: rationale and design.
Circulation journal : official journal of the Japanese Circulation Society 2006;70(5):548-52.
2006: Tsuneo Takenaka; Hirokazu Okada; Yoshihiko Kanno; Tsutomu Inoue; Munekazu Ryuzaki; Hidetomo Nakamoto; Hiroshi Kawachi; Fujio Shimizu; Hiromichi Suzuki
Exogenous 5'-nucleotidase improves glomerular autoregulation in Thy-1 nephritic rats.
American journal of physiology. Renal physiology 2006;290(4):F844-53.
2006: Hidetomo Nakamoto; Yoshindo Kawaguchi; Hiromichi Suzuki
Is technique survival on peritoneal dialysis better in Japan?
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2006;26(2):136-43.
2006: Hirokazu Okada; Tomohiro Kikuta; Tsutomu Inoue; Yoshihiko Kanno; Shinichi Ban; takeshi sugaya; Masaharu Takigawa; Hiromichi Suzuki
Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner.
The American journal of pathology 2006;168(3):737-47.
2006: Tsuneo Takenaka; Yoshihiko Kanno; Hirokazu Okada; Hidetomo Nakamoto; Hiromichi Suzuki
[Molecular mechanisms underlying renal hypertension].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 2():381-4.
2006: Hiromichi Suzuki; Yoshihiko Kanno; Tsuneo Takenaka
[Aldosterone/cortisol: its molecular pathway from synthesis to function].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 2():265-70.
2006: Hiroshi Arima; Hidetomo Nakamoto; Saiko Okada; Tsutomu Inoue; Kazuhiko Kobayashi; Junko Shoda; Naofumi Ikeda; Yoshihiko Kanno; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Risk factors for vascular complications in patients on peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2006;22():192-7.
2006: Hitoshi Hoshi; Hidetomo Nakamoto; Yoshihiko Kanno; Hiroshi Takane; Naofumi Ikeda; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Long-term follow-up of patients treated with a combination of continuous ambulatory peritoneal dialysis and hemodialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2006;22():136-40.
2006: Hiromichi Suzuki; Tsutomu Inoue; Kazuhiro Kobayashi; Junko Shoda; Hidetomo Nakamoto
The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2006;22():18-23.
2006: Hidetomo Nakamoto; Hirokazu Imai; Hideki Kawanishi; Masahiko Nakamoto; Jun Minakuchi; Shinichi Kumon; Syuichi Watanabe; Yoshiki Shiohira; Takeo Ishii; Toshihiko Kawahara; Hiromichi Suzuki
Early estimation of high peritoneal permeability can predict poor prognosis for technique survival in patients on peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2006;22():11-7.
2006: Yusuke Watanabe; Tsutomu Inoue; Hirokazu Okada; Syuhei Kotaki; Yoshihiko Kanno; Tomohiro Kikuta; Hiromichi Suzuki
Impact of selectin gene polymorphisms on rapid progression to end-stage renal disease in patients with IgA nephropathy.
Internal medicine (Tokyo, Japan) 2006;45(16):947-51.
2006: Junko Shoda; Yoshihiko Kanno; Hiromichi Suzuki
A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy.
Internal medicine (Tokyo, Japan) 2006;45(4):193-8.
2005: Tsuneo Takenaka; Taku Mimura; Yoshihiko Kanno; Hiromichi Suzuki
Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases.
American journal of nephrology 2005;25(5):417-24.
2005: Hiroshi Takane; Hiromichi Suzuki
[Treatment recommendations for various stages in diabetic nephropathy].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 6():379-83.
2005: Tatsuya Kobayashi; Tsutomu Inoue; Hirokazu Okada; Tomohiro Kikuta; Yoshihiko Kanno; Takashi Nishida; Masaharu Takigawa; takeshi sugaya; Hiromichi Suzuki
Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose.
Clinical and experimental nephrology 2005;9(2):114-21.
2005: Kazuhiro Kobayashi; Yoshihiko Kanno; Hiromichi Suzuki
[Treatment for the elderly hypertensive patient with renal insufficiency].
Nihon rinsho. Japanese journal of clinical medicine 2005;63(6):1047-51.
2005: Hiromichi Suzuki; Yoshihiko Kanno
Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
Hypertension research : official journal of the Japanese Society of Hypertension 2005;28(4):307-14.
2005: Yoshihiko Kanno; Hirokazu Okada; Y Yamaji; Y Nakazato; Hiromichi Suzuki
Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
QJM : monthly journal of the Association of Physicians 2005;98(3):199-203.
2005: Hiromichi Suzuki; Yoshihiko Kanno; Hidetomo Nakamoto; Hirokazu Okada; Soichi Sugahara
Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2005;27(2-3):129-38.
2005: Taku Mimura; Tsuneo Takenaka; Yoshihiko Kanno; Hiroaki Aoki; Joji Ohshima; Hiromichi Suzuki
Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2005;21():139-45.
2005: Hirokazu Okada; Tomohiro Kikuta; Tatsuya Kobayashi; Tsutomu Inoue; Yoshihiko Kanno; Masaharu Takigawa; takeshi sugaya; Jeffrey Kopp; Hiromichi Suzuki
Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis.
Journal of the American Society of Nephrology : JASN 2005;16(1):133-43.
2004: Hirokazu Okada; Yusuke Watanabe; Syuhei Kotaki; Naofumi Ikeda; Hiroshi Takane; Yoshihiko Kanno; Soichi Sugahara; Shinichi Ban; Makoto Nagata; Hiromichi Suzuki
An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(5):902-7.
2004: Souichi Sugahara; Hiromichi Suzuki
Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery.
Hemodialysis international. International Symposium on Home Hemodialysis 2004;8(4):320-5.
2004: Hirokazu Okada; Yusuke Watanabe; Tomohiro Kikuta; Tatsuya Kobayashi; Yoshihiko Kanno; takeshi sugaya; Hiromichi Suzuki
Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade.
Journal of the American Society of Nephrology : JASN 2004;15(9):2404-13.
2004: Hiromichi Suzuki; Yoshihiko Kanno; Keiko Kaneko; Masaharu Kaneko; Syuhei Kotaki; Taku Mimura; Hiroshi Takane
Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(4):320-7.
2004: Hiromichi Suzuki
[Hemodialysis-associated hypertension; pathophysiology and therapy].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():220-4.
2004: Hiromichi Suzuki
[Renin-angiotensin-aldosterone system].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():153-6.
2004: Hiromichi Suzuki; Yoshihiko Kanno; Soichi Sugahara; Hirokazu Okada; Hidetomo Nakamoto
Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(6):1056-64.
2004: Hiromichi Suzuki
[A various types of CAPD--focused on APD].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 5():293-6.
2004: Hiromichi Suzuki
[Ectopic ACTH syndrome].
Nihon rinsho. Japanese journal of clinical medicine 2004;62(5):951-5.
2004: Hirokazu Okada; Yusuke Watanabe; Tatsuya Kobayashi; Tomohiro Kikuta; Yoshihiko Kanno; Hiromichi Suzuki
Angiotensin II type 1 and type 2 receptors reciprocally modulate pro-inflammatory/ pro-fibrotic reactions in activated splenic lymphocytes.
American journal of nephrology 2004;24(3):322-9.
2004: Hiromichi Suzuki
[Renal parenchymal disease and hypertension].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 3():503-7.
2004: Hiromichi Suzuki
[Evaluation of renal function in hypertensive patients].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 3():315-20.
2004: Yoshihiko Kanno; Keiko Kaneko; Masaharu Kaneko; Syuhei Kotaki; Taku Mimura; Hiroshi Takane; Hiromichi Suzuki
Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients.
Journal of cardiovascular pharmacology 2004;43(3):380-6.
2004: Hirokazu Okada; Yusuke Watanabe; Tsutomu Inoue; Tatsuya Kobayashi; Tomohiro Kikuta; Yoshihiko Kanno; Shinichi Ban; Hiromichi Suzuki
Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor.
Biochemical and biophysical research communications 2004;314(2):403-8.
2004: Yoshihiko Kanno; Hirokazu Okada; Hidetomo Nakamoto; Hiromichi Suzuki
Clinical strategy for the treatment of hypertension in non-diabetic and diabetic nephropathy in Japan.
Contributions to nephrology 2004;143():145-58.
2004: Hiromichi Suzuki; Takao Saruta
An overview of blood pressure regulation associated with the kidney.
Contributions to nephrology 2004;143():1-15.
2004: Lirong Hao; Yoshihiko Kanno; Rie Fukushima; Yusuke Watanabe; Yuji Ishida; Hiromichi Suzuki
Effects of eplerenone on heart and kidney in two-kidney, one-clip rats.
American journal of nephrology 2004;24(1):54-60.
2003: Hidetomo Nakamoto; Hiromichi Suzuki
Hypoproteinemia in patients with diabetes undergoing continuous ambulatory peritoneal dialysis is attributable to high permeability of peritoneal membrane.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2003;23 Suppl 2():S72-8.
2003: Hirokazu Okada; Yusuke Watanabe; Tsutomu Inoue; Tatsuya Kobayashi; Yoshihiko Kanno; Goshi Shiota; Toshikazu Nakamura; takeshi sugaya; Akiyoshi Fukamizu; Hiromichi Suzuki
Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2515-23.
2003: Hirokazu Okada; Tsutomu Inoue; Yoshihiko Kanno; Tatsuya Kobayashi; Yusuke Watanabe; Shinichi Ban; Eric G Neilson; Hiromichi Suzuki
Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome.
Kidney international 2003;64(5):1722-32.
2003: Lirong Hao; Hirokazu Okada; Yoshihiko Kanno; Tsutomu Inoue; Tatsuya Kobayashi; Yusuke Watanabe; Frank Strutz; Gerhard A Müller; Hiromichi Suzuki
Direct contact between human peripheral blood mononuclear cells and renal fibroblasts facilitates the expression of monocyte chemoattractant protein-1.
American journal of nephrology 2003;23(4):208-13.
2003: Yoshihiko Kanno; Martje Witt; Hirokazu Okada; Hironori Nemoto; Soichi Sugahara; Hidetomo Nakamoto; Hiromichi Suzuki
A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Clinical and experimental nephrology 2003;7(1):48-51.
2003: Hiroe Imai; Hidetomo Nakamoto; Rie Fukushima; Yuji Ishida; Yasuhito Yamanouchi; Hiromichi Suzuki
Role of adhesion molecules in the progression of peritoneal sclerosis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():180-5.
2003: Toshihiko Suzuki; Yoshihiko Kanno; Hidetomo Nakamoto; Hirokazu Okada; Soichi Sugahara; Hiromichi Suzuki
Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():148-54.
2003: Yoshihiko Kanno; Hiromichi Suzuki; Hidetomo Nakamoto; Hirokazu Okada; Soichi Sugahara
Once-weekly hemodialysis helps continuous ambulatory peritoneal dialysis patients who have insufficient solute removal.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():143-7.
2003: Koji Tomori; Hidetomo Nakamoto; Syuhei Kotaki; Yuji Ishida; Hiroshi Takane; Hironori Nemoto; Yoshihiko Kanno; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Gastric angiodysplasia in patients undergoing maintenance dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():136-42.
2003: Hidetomo Nakamoto; Atsushi Kawamoto; Yoshimasa Tanabe; Yoshinori Nakagawa; Eiichi Nishida; Takashi Akiba; Hiromichi Suzuki
Telemedicine system using a cellular telephone for continuous ambulatory peritoneal dialysis patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():124-9.
2003: Hidetomo Nakamoto; Hiroshi Takane; Soichi Sugahara; Yoshihiko Kanno; Hirokazu Okada; Tadashi Yamamoto; Hiromichi Suzuki
Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():97-102.
2003: Yuji Ishida; Koji Tomori; Hidetomo Nakamoto; Hiroe Imai; Hiromichi Suzuki
Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():10-4.
2003: Yoshihiko Kanno; Hironori Nemoto; Hidetomo Nakamoto; Hirokazu Okada; Soichi Sugahara; Koichiro Nishidome; Yoshihisa Yamashita; Hiromichi Suzuki
Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 2003;6(3):205-10.
2002: Ruri Chihara; Hidetomo Nakamoto; Hiroshi Arima; Kenshi Moriwaki; Yoshihiko Kanno; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Systemic capillary leak syndrome.
Internal medicine (Tokyo, Japan) 2002;41(11):953-6.
2002: Yoshihiko Kanno; Hirokazu Okada; Kenshi Moriwaki; Shizuko Nagao; Hisahide Takahashi; Hiromichi Suzuki
The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats.
Hypertension research : official journal of the Japanese Society of Hypertension 2002;25(6):939-43.
2002: Hiromichi Suzuki; Yoshihiko Kanno; Naofumi Ikeda; Hidetomo Nakamoto; Hirokazu Okada; Soichi Sugahara
Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy.
Hypertension research : official journal of the Japanese Society of Hypertension 2002;25(6):865-73.
2002: Hidetomo Nakamoto; Hirokazu Imai; Hideki Kawanishi; Masahiko Nakamoto; Jun Minakuchi; Shinichi Kumon; Syuichi Watanabe; Yoshiki Shiohira; Takeo Ishii; Toshihiko Kawahara; Koichi Tsuzaki; Hiromichi Suzuki
Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(5):1045-54.
2002: Hiromichi Suzuki
[Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 10():323-8.
2002: Hiromichi Suzuki
[Large scale clinical trials in prevention of end-stage renal disease due to type 2 diabetes with angiotensin receptor antagonists].
Nihon rinsho. Japanese journal of clinical medicine 2002;60(10):2040-4.
2002: Hirokazu Okada; Naofumi Ikeda; Tatsuya Kobayashi; Tsutomu Inoue; Yoshihiko Kanno; Soichi Sugahara; Hidetomo Nakamoto; Takako Yamamoto; Hiromichi Suzuki
An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis.
Nephron 2002;92(2):440-4.
2002: Tsutomu Inoue; Hirokazu Okada; Tatsuya Kobayashi; Yusuke Watanabe; Tomohiro Kikuta; Yoshihiko Kanno; Masaharu Takigawa; Hiromichi Suzuki
TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme.
Biochemical and biophysical research communications 2002;297(2):255-60.
2002: Hirokazu Okada; Tsutomu Inoue; Yoshihiko Kanno; Tatsuya Kobayashi; Yusuke Watanabe; Jeffrey Kopp; Robert M Carey; Hiromichi Suzuki
Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney.
The American journal of pathology 2002;160(3):765-72.
2002: Hiroe Imai; Hidetomo Nakamoto; Rie Fucshima; Yasuhito Yamanouchi; Yuji Ishida; Hiromichi Suzuki
Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2002;18():124-30.
2002: Hidetomo Nakamoto; Yoshindo Kawaguchi; Hiromichi Suzuki
Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2002;18():119-23.
2002: Naofumi Ikeda; Hiromichi Suzuki; Kenshi Moriwaki; Soichi Sugahara; Yoshihiko Kanno; Hirokazu Okada; Hidetomo Nakamoto
Intensive blood pressure reduction is beneficial in patients with impaired cardiac function coexisting with chronic renal insufficiency.
Hypertension research : official journal of the Japanese Society of Hypertension 2002;25(1):41-8.
2002: Hiromichi Suzuki; K Moriwaki; Hidetomo Nakamoto; Soichi Sugahara; Yoshihiko Kanno; Hirokazu Okada
Blood pressure reduction in the morning yields beneficial effects on progression of chronic renal insufficiency with regression of left ventricular hypertrophy.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2002;24(1-2):51-63.
2001: Yoshihiko Kanno; Hirokazu Okada; H Nemoto; S Sugahara; H Nakamoto; Hiromichi Suzuki
Crystal nephropathy: a variant form of myeloma kidney--a case report and review of the literature.
Clinical nephrology 2001;56(5):398-401.
2001: Hirokazu Okada; Tsutomu Inoue; Yoshihiko Kanno; Tatsuya Kobayashi; Shinichi Ban; R Kalluri; Hiromichi Suzuki
Renal fibroblast-like cells in Goodpasture syndrome rats.
Kidney international 2001;60(2):597-606.
2001: G W Rose; Yoshihiko Kanno; H Ikebukuro; M Kaneko; K Kaneko; T Kanno; Yuji Ishida; Hiromichi Suzuki
Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.
Hypertension research : official journal of the Japanese Society of Hypertension 2001;24(4):377-83.
2001: Hiromichi Suzuki; Takao Saruta
Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2001;23(3):189-201.
2001: Hiromichi Suzuki; Kenshi Moriwaki; Yoshihiko Kanno; Hidetomo Nakamoto; Hirokazu Okada; X M Chen
Comparison of the effects of an ACE inhibitor and alphabeta blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report.
Hypertension research : official journal of the Japanese Society of Hypertension 2001;24(2):153-8.
2001: S Takahira; Yoshihiko Kanno; Hirokazu Okada; Soichi Sugahara; Hidetomo Nakamoto; Hiromichi Suzuki
Improved outcome prediction for patients with multiple organ failure undergoing continuous hemodiafiltration.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2001;5(1):31-5.
2001: Hidetomo Nakamoto; Hiroe Imai; Yuji Ishida; Yasuhito Yamanouchi; Tsutomu Inoue; Hirokazu Okada; Hiromichi Suzuki
New animal models for encapsulating peritoneal sclerosis--role of acidic solution.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2001;21 Suppl 3():S349-53.
2001: Hidetomo Nakamoto; Hiroe Imai; Hideki Kawanishi; Masahiko Nakamoto; Jun Minakuchi; Shinichi Kumon; Syuichi Watanabe; Yoshiki Shiohira; Takeo Ishii; Toshihiko Kawahara; Hiromichi Suzuki
Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2001;17():238-43.
2001: Hiroe Imai; Hidetomo Nakamoto; Yuji Ishida; Yasuhito Yamanouchi; Tsutomu Inoue; Hirokazu Okada; Hiromichi Suzuki
Renin-angiotensin system plays an important role in the regulation of water transport in the peritoneum.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2001;17():20-4.
2001: Yuji Ishida; Hidetomo Nakamoto; Hiroe Imai; S Suzuki; H Okano; Hiromichi Suzuki
Heme oxygenase-1 regulates vascular tone of the peritoneum undergoing peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2001;17():15-9.
2000: Yoshihiko Kanno; Hirokazu Okada; Takao Saruta; Hiromichi Suzuki
Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Clinical nephrology 2000;54(5):360-5.
2000: Hiromichi Suzuki
Treatment of hypertension in chronic renal insufficiency.
Internal medicine (Tokyo, Japan) 2000;39(10):773-7.
2000: Hirokazu Okada; K Moriwaki; Yoshihiko Kanno; Soichi Sugahara; Hidetomo Nakamoto; M Yoshizawa; Hiromichi Suzuki
Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(9):1410-3.
2000: Hirokazu Okada; K Moriwaki; K Konishi; Tatsuya Kobayashi; Soichi Sugahara; Hidetomo Nakamoto; T Saruta; Hiromichi Suzuki
Tubular osteopontin expression in human glomerulonephritis and renal vasculitis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;36(3):498-506.
2000: Yoshihiko Kanno; Hirokazu Okada; T Takenaka; Takao Saruta; Hiromichi Suzuki
Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2000;22(5):521-9.
2000: Hiromichi Suzuki; Hidetomo Nakamoto; H Nemoto; Soichi Sugahara; Hirokazu Okada
Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine.
Hypertension research : official journal of the Japanese Society of Hypertension 2000;23(2):159-66.
2000: Hirokazu Okada; K Moriwaki; R Kalluri; H Imai; Shinichi Ban; M Takahama; Hiromichi Suzuki
Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome.
Kidney international 2000;57(3):927-36.
2000: Hirokazu Okada; Tsutomu Inoue; Hiromichi Suzuki; Frank Strutz; E G Neilson
Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15 Suppl 6():44-6.
2000: K Moriwaki; Yoshihiko Kanno; Hidetomo Nakamoto; Hirokazu Okada; Hiromichi Suzuki
Vitamin B6 deficiency in elderly patients on chronic peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2000;16():308-12.
2000: Hiroe Imai; Hidetomo Nakamoto; Yuji Ishida; Tsutomu Inoue; Yoshihiko Kanno; Hirokazu Okada; S Suzuki; H Okano; Hiromichi Suzuki
Glucocorticoid restores the deterioration of water transport in the peritoneum through increment in aquaporin.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2000;16():297-302.
2000: Hidetomo Nakamoto; M Hatta; A Tanaka; K Moriwaki; K Oohama; K Kagawa; K Wada; Hiromichi Suzuki
Telemedicine system for home automated peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2000;16():191-4.
2000: J Shoda; Hidetomo Nakamoto; Hirokazu Okada; Hiromichi Suzuki
Impact of introduction of continuous ambulatory peritoneal dialysis on blood pressure: analysis of 24-hour ambulatory blood pressure.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2000;16():97-101.
2000: Hiromichi Suzuki
[Urinary abnormalities in patients with hypertension].
Nihon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 1():775-9.
2000: Hiromichi Suzuki
[Pathogenesis of renal damage due to hypertension].
Nihon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 1():770-3.
2000: Hiromichi Suzuki
[Renal damage due to hypertension: an overview].
Nihon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 1():766-9.
2000: Hirokazu Okada; K Moriwaki; R Kalluri; Tsuneo Takenaka; H Imai; Shinichi Ban; M Takahama; Hiromichi Suzuki
Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats.
American journal of physiology. Renal physiology 2000;278(1):F110-21.
1999: Hidetomo Nakamoto; H Nemoto; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Nifedipine and arotinolol in combination for accelerated-malignant hypertension: results of one year follow-up.
Hypertension research : official journal of the Japanese Society of Hypertension 1999;22(2):75-80.
1999: Hirokazu Okada; Munekazu Ryuzaki; Syuhei Kotaki; Hidetomo Nakamoto; Soichi Sugahara; K Kaneko; T Yamamoto; H Kawahara; Hiromichi Suzuki
Thoracoscopic surgery and pleurodesis for pleuroperitoneal communication in patients on continuous ambulatory peritoneal dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(1):170-2.
1999: Hirokazu Okada; S Takahira; Soichi Sugahara; Hidetomo Nakamoto; Hiromichi Suzuki
Retroperitoneal fibrosis and systemic lupus erythematosus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(5):1300-2.
1999: Hirokazu Okada; I Tsukamoto; Soichi Sugahara; Hidetomo Nakamoto; K Oohama; Y Yamashita; Y Yokote; R Omoto; Hiromichi Suzuki
Does intensive perioperative dialysis improve the results of coronary artery bypass grafting in haemodialysed patients?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(3):771-5.
1999: Hirokazu Okada; Tsutomu Inoue; S Takahira; Soichi Sugahara; Hidetomo Nakamoto; Hiromichi Suzuki
Daytime hypertension, sleep apnea and metabolic alkalosis in a haemodialysis patient--the result of sodium bicarbonate abuse.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(2):452-4.
1999: Hiroshi Takane; Hidetomo Nakamoto; K Moriwaki; Hironori Nemoto; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Evidence that gender difference affects peritoneal dialysis capacity in continuous ambulatory peritoneal dialysis patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1999;15():156-9.
1999: J Shouda; Hidetomo Nakamoto; Soichi Sugahara; Hirokazu Okada; Hiromichi Suzuki
Incidence of gingival hyperplasia caused by calcium antagonists in continuous ambulatory peritoneal dialysis patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1999;15():153-5.
1998: Hidetomo Nakamoto; C M Ferrario; V M Buckalew; Hiromichi Suzuki
Role of nitric oxide in the evolution of renal ischemia in two-kidney, one-clip renovascular hypertension.
Hypertension research : official journal of the Japanese Society of Hypertension 1998;21(4):267-77.
1997: Hirokazu Okada; K Moriwaki; Soichi Sugahara; Hidetomo Nakamoto; T Hosokawa; K Hamaguchi; Hiromichi Suzuki
Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1997;1(4):343-7.